March 17, 2017
A Galena BioPharma Inc. investor on Thursday hit the California-based pharmaceutical company with a derivative suit in New Jersey federal court alleging that its directors misled investors and mismanaged the company in regard to illegal marketing practices of fentanyl tablets.